# The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER)

> **NCT01246804** · PHASE1 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 18 (actual)

## Conditions studied

- HIV Infections
- Depression
- Mild Cognitive Impairment

## Interventions

- **DRUG:** raltegravir single dose
- **DRUG:** ginkgo biloba multiple dose

## Key facts

- **NCT ID:** NCT01246804
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-03
- **Final completion:** 2011-05
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01246804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01246804, "The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01246804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*